Kestra Advisory Services’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Kestra Advisory Services’s Portfolio GRTX Stock Details GRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-32,250	Closed	-$4.51K	–	2706
2024 Q1	$4.51K	Sell	32,250 -3,500	-10%	-$690	﹤0.01%	2445
2023 Q4	$5.2K	Sell	35,750 -50,000	-58%	-$7.76K	﹤0.01%	2265
2023 Q3	$15K	Buy	+85,750	New	+$107K	﹤0.01%	2089

Other funds holding GRTX

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Kestra Advisory Services's GRTX Position: Q2 2024 in Review

Kestra Advisory Services sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q2 2024, closing a stake of 32,250 shares — an estimated $4.51K sold.

Kestra Advisory Services first reported a position in GRTX in Q3 2023 and held it in 3 quarters. The position peaked at $15K in Q3 2023. 1 fund tracked by Wall St. Rank holds GRTX as of Q2 2024.

Kestra Advisory Services reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Kestra Advisory Services sold 32,250 Galera Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $4.51K.
Kestra Advisory Services first reported a position in Galera Therapeutics, Inc. Common Stock in Q3 2023 and held it in 3 quarters.
Kestra Advisory Services's Galera Therapeutics, Inc. Common Stock position peaked at $15K in Q3 2023.
1 fund tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q2 2024.

Based on Kestra Advisory Services's 13F filing for Q2 2024, filed 14 Aug 2024.